2026-01-11 - Analysis Report
## AVGO (Broadcom Inc) Investment Performance Report

Broadcom Inc is a global technology company that designs, develops, and supplies a broad range of semiconductor and infrastructure software solutions.

---

### 1) Return Comparison and Historical Analysis

| Metric | AVGO (Broadcom Inc) | VOO (S&P 500) | Analysis |
| :--- | :--- | :--- | :--- |
| **Cumulative Return** | 257.78% | 94.03% | **AVGO significantly outperformed the broader market.** |
| **Divergence** | 163.8 percentage points | N/A | AVGO’s cumulative return is 163.8 percentage points higher than the S&P 500. |
| **Relative Divergence** | 70.6 | N/A | The current divergence level is in the top 70.6% of its historical fluctuation range, indicating that the stock is performing exceptionally well relative to the benchmark compared to historical data. |

#### Alpha, Beta, and Historical Volatility Analysis

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| :--- | :--- | :--- | :--- | :--- | :--- |
| 2016-2018 | 27.0% | 21.8% | 23.0% | 1.3 | 120.6 |
| 2017-2019 | 32.0% | 21.8% | 15.0% | 1.3 | 149.8 |
| 2018-2020 | 68.0% | 21.8% | 47.0% | 1.2 | 207.6 |
| 2019-2021 | 91.0% | 16.9% | 48.0% | 1.3 | 315.5 |
| 2020-2022 | 4.0% | 32.6% | 5.0% | 1.3 | 265.1 |
| 2021-2023 | 32.0% | 32.6% | 32.0% | 1.4 | 529.2 |
| **2022-2024** | **137.0%** | 29.8% | **118.0%** | **1.6** | **1,099.2** |
| **2023-2025** | **208.0%** | 35.6% | **146.0%** | **1.9** | **1,641.0** |

**Simple Analysis:**

Broadcom has demonstrated extraordinary growth acceleration in the most recent periods (2022-2025). The CAGR jumped from a high of 91.0% (2019-2021) to 208.0% (2023-2025), reflecting massive upside potential, likely driven by infrastructure software growth and AI-related semiconductor demand.

This explosive growth is accompanied by increased risk:
1.  **Alpha:** Alpha surged, confirming the stock’s extreme ability to generate returns far in excess of the market (146.0% in the latest period).
2.  **Beta:** Beta has risen sharply from the typical 1.2–1.3 range to **1.9** (2023-2025). This indicates the stock is highly correlated with and significantly more volatile than the overall market.
3.  **Market Cap:** The company has transitioned into a massive growth powerhouse, with its market capitalization ballooning to $1,641.0 billion.
4.  **MDD:** Maximum Drawdown has also increased (35.6%), reflecting the greater risk associated with the increased volatility.

---

### 2) Recent Stock Price Fluctuations (Moving Average Analysis)

| Metric | Value |
| :--- | :--- |
| **Close** | 344.97 |
| **Last Change** | +3.79 (Sharp Rebound) |
| **5-day SMA** | 341.63 |
| **20-day SMA** | 346.89 |
| **60-day SMA** | 359.08 |

**Simple Analysis:**

The stock closed at 344.97, showing a strong single-day rebound (Last Change: +3.79). However, a review of moving averages suggests the stock is currently in a short-to-medium-term downtrend or consolidation:
*   The current price is *above* the very short-term (5-day) average, indicating recent buying pressure.
*   The current price is *below* both the 20-day and 60-day SMAs. This pattern confirms that despite the recent positive fluctuation, the stock is struggling below key resistance levels, suggesting that the broader medium-term momentum has been bearish.

---

### 3) Technical Indicators and Risk Assessment

| Indicator | Value | Interpretation |
| :--- | :--- | :--- |
| **Market Risk Indicator (MRI)** | 0.7 | Low Investment Recommended (suggests caution). |
| **RSI** | 62.78 | Indicates strong underlying momentum, but not yet overbought (>70). |
| **PPO** | -0.1674 | Negative PPO confirms the 5-day MA is currently below the 20-day MA, signaling a short-term bearish trend continuation. |
| **Recent Relative Divergence Change** | -2.3 | Indicates a short-term decline in outperformance compared to the benchmark. |
| **Expected Return (%)** | 39.5 | High expected excess return compared to the S&P 500 over a long-term investment horizon (2+ years). |
| **Hybrid Signal** | cash\_0%\_Buy 100% | Aggressive buy recommendation (contradicts the conservative MRI). |

**Simple Analysis:**

Technical signals present a mixed picture: The MRI suggests caution, aligning with the negative PPO and the recent moving average analysis (short-term weakness). However, the RSI remains strong (62.78), and the long-term expected return (39.5%) is very high. The recent daily fluctuation (+3.79) suggests a sharp rebound attempt following the short-term decline indicated by the divergence change (-2.3).

---

### 4) Recent News & Significant Events

| Date | Headline/Event | Context |
| :--- | :--- | :--- |
| 2026-01-08 | Why Broadcom Stock Fell 14.1% in December | Notes significant recent volatility and sharp decline. |
| 2026-01-09 | Cathie Wood Buys the Dip in Broadcom Stock (AVGO) as Wall Street Grows More Bullish | Indicates high-profile institutional interest taking advantage of the recent dip. |
| 2026-01-11 | Cathie Wood’s ARK Takes a New Stake in Broadcom | Further confirmation of institutional conviction following the price correction. |
| 2026-01-08 | Broadcom: Ready To Close Undervaluation Gap in 2026 | Seeking Alpha analysis suggesting the recent dip offers a favorable entry point. |

#### Analyst Opinions

| Metric | Value |
| :--- | :--- |
| **Consensus** | Strong Buy |
| **Mean Rating** | 1.27 (out of 5) |
| **Number of Opinions** | 43 |
| **Average Target Price** | $457.73 |
| **Current Price** | $344.97 |

**Analysis:**

Recent news confirms a period of high volatility characterized by a steep decline in December, which was quickly met by aggressive "buy the dip" action from institutional investors like Cathie Wood. Despite the volatility, Wall Street sentiment remains overwhelmingly positive, with a **Strong Buy** consensus and an average target price of $457.73, suggesting approximately 32.7% upside potential from the current closing price.

---

### 5) Recent Earnings Analysis

| Date | EPS | Revenue |
| :--- | :--- | :--- |
| 2025-09-10 | 0.88 | $15.95 B |
| 2025-06-11 | 1.05 | $15.00 B |
| 2025-03-12 | 1.17 | $14.92 B |
| 2024-09-11 | -0.4 | $13.07 B |
| 2025-09-10 | -0.4 | $13.07 B |

**Simple Analysis:**

Broadcom demonstrates a strong upward trajectory in revenue, increasing from $13.07 billion to $15.95 billion over the comparable period. EPS figures show significant recent recovery and growth (from $0.88 to $1.17 in the first three quarters of 2025), following a period where non-GAAP EPS was negative (likely due to acquisition costs or large one-time charges in late 2024). The sequential revenue growth underscores powerful business momentum.

---

### 6) Financial Information

#### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
| :--- | :--- | :--- |
| 2025-10-31 | $18.02B | 67.99% |
| 2025-07-31 | $15.95B | 67.10% |
| 2025-04-30 | $15.00B | 67.96% |
| 2025-01-31 | $14.92B | 68.01% |
| 2024-10-31 | $14.05B | 64.05% |

**Analysis:** Revenue shows robust sequential quarterly increases, peaking at $18.02 billion in the latest reported quarter. Critically, the **Profit Margin is exceptionally high and stable**, consistently around 67-68%. This signifies high pricing power and excellent cost control, typical of a dominant technology leader.

#### Capital and Profitability (ROE)

| Quarter | Equity | ROE |
| :--- | :--- | :--- |
| 2025-10-31 | $81.29B | 10.48% |
| 2025-07-31 | $73.28B | 5.65% |
| 2025-04-30 | $69.59B | 7.14% |
| 2025-01-31 | $69.79B | 7.89% |
| 2024-10-31 | $67.68B | 6.39% |

**Analysis:** Shareholders' Equity has increased substantially, growing from $67.68 billion to $81.29 billion. Return on Equity (ROE) shows healthy growth and strong volatility, spiking to 10.48% in the most recent quarter. This high ROE confirms the company's superior ability to generate profit from shareholder investments, aligning with the exceptional operating profit margins.

---

### 7) Comprehensive Analysis (Summary)

Broadcom (AVGO) is characterized by **extreme growth, high alpha, and high volatility.** Historically, it has massively outperformed the S&P 500 (Divergence: +163.8%). Recent analysis shows its growth momentum is explosive (208.0% CAGR), but this comes at the cost of significantly increased market risk (Beta 1.9).

**Financial Health:** The company is financially superb, marked by strong sequential revenue growth and extraordinarily high and stable operating profit margins (around 68%). The recent spike in ROE (10.48%) suggests efficient capital deployment.

**Recent Technical Status:** The stock is currently undergoing a period of **short-term weakness or consolidation**. Despite a strong recent daily rebound, the price remains below the 20-day and 60-day moving averages (confirmed by the negative PPO). This recent dip aligns with the news reports of a sharp December decline.

**Outlook:** Investor sentiment (Hybrid Signal/Expected Return) and analyst consensus (Strong Buy, $457.73 target) are strongly bullish, viewing the recent pullback as a buying opportunity (as evidenced by institutional accumulation). The high MRI (0.7) and high Beta (1.9) mandate caution, indicating that while long-term potential is robust (39.5% expected excess return), short-term price fluctuations will be severe. AVGO is best suited for growth-oriented investors with a high tolerance for volatility.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.